Keratoacanthoma associated with the use of topical imiquimod

Clinical and Experimental Dermatology

Volumn 38, Issue 5, 2013, Pages 555-556

  Campalani, E ^a   Holden, C A ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; KERATIN;

ADULT; BASAL CELL CARCINOMA; CANCER SIZE; CASE REPORT; CELL NUCLEUS; CLAVICLE; CREAM; HISTOPATHOLOGY; HUMAN; KERATOACANTHOMA; LETTER; MALE; NON MELANOMA SKIN CANCER; PRESCRIPTION; PRIORITY JOURNAL; SKIN NODULE; SQUAMOUS EPITHELIUM; TUMOR DIFFERENTIATION;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; HUMANS; KERATOACANTHOMA; MALE; MIDDLE AGED;

EID: 84879230133     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04476.x     Document Type: Letter

References (5)

1. Pattee SF, Silvis NG,. Keratoacanthoma developing in sites of previous trauma: a report of two cases and review of the literature. J Am Acad Dermatol 2003; 48 (Suppl.): S35-8.
2. Gewirtzman A, Meirson DH, Rabinovitz H,. Eruptive keratoachanthomas following carbon dioxide laser resurfacing. Dermatol Surg 1999; 25: 666-8.
3. Dessoukey MW, Omar MF, Abdel-Dayem H,. Eruptive keratoachantomas associated with immunosuppressive therapy in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1997; 37: 478-80.
4. D'Addario S, Carrington PR,. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses. Acta Derm Venereol 2006; 86: 366-7.
5. Marcollo Pini A, Koch S, Scharer L, et al. Eruptive keratoacanthomas following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. J Am Acad Dermatol 2008; 59: S116-17.